Skip to main content

Table 2 C3a, C4a and C5a plasma levels in nAMD patients and controls

From: Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration

   

Univariate analysis

Multivariate analysis (age and gender)

Multivariate analysis (age, gender and family history of AMD)

Variables (ng/ml)

Controls (mean ± SD) n = 43

nAMD (mean ± SD) n = 96

P value

nAMD vs Controlsa

P value

nAMD vs Controlsb

Odds ratio

95 % confidence interval for odds ratio

P value

nAMD vs Controlsc

Odds ratio

95 % confidence interval for odds ratio

C3a

11.95 ± 3.30

14.65 ± 4.48

<0.001

0.001

241.44

8.44–6910.14

0.005

140.67

4.53–4372.57

C4a

68.91 ± 33.23

108.48 ± 83.83

0.005

0.012

5.81

1.46–23.05

0.031

4.79

1.15–19.88

C5a

8.34 ± 2.05

9.43 ± 2.73

0.049

0.045

20.55

1.07–396.06

   
  1. aIndependent samples t-test
  2. bMultinomial logistic regression corrected for age and gender
  3. cMultinomial logistic regression corrected for age, gender and family history of AMD
  4. Bold P < 0.05
  5. SD standard deviation